Related Experiment Video
Updated: Feb 9, 2026

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Published on: October 24, 2019
Adoptive Transfer of Interleukin-21-stimulated Human CD8+ T Memory Stem Cells Efficiently Inhibits Tumor Growth
Yingshi Chen1,2,3, Fei Yu1,2,3, Yawen Jiang1,2,3
1Institute of Human Virology.
Abstract:
Memory stem T (TSCM) cells, a new subset of memory T cells with self-renewal and multipotent capacities, are considered as a promising candidates for adoptive cellular therapy. However, the low proportion of human TSCM cells in total CD8 T cells limits their utility. Here, we aimed to induce human CD8 TSCM cells by stimulating naive precursors with interleukin-21 (IL-21). We found that IL-21 promoted the generation of TSCM cells, described as CD45RACD45ROCD62LCCR7CD122CD95 cells, with a higher efficiency than that observed with other common γ-chain cytokines. Upon adoptive transfer into an A375 melanoma mouse model, these lymphocytes mediated much stronger antitumor responses. Further mechanistic analysis revealed that IL-21 activated the Janus kinase signal transducer and activator of transcription 3 pathway by upregulating signal transducer and activator of transcription 3 phosphorylation and consequently promoting the expression of T-bet and suppressor of cytokine signaling 1, but decreasing the expression of eomesodermin and GATA binding protein 3. Our findings provide novel insights into the generation of human CD8 TSCM cells and reveal a novel potential clinical application of IL-21.
Insights
Interleukin-21 (IL-21) effectively generates memory stem T (TSCM) cells from human CD8 T cells. These engineered TSCM cells demonstrate enhanced anti-melanoma efficacy in preclinical models.
Area of Science:
- Immunology
- Cell Biology
- Cancer Therapy
Background:
- Memory stem T (TSCM) cells possess self-renewal and multipotent properties, making them valuable for adoptive cell therapy.
- The limited natural abundance of human TSCM cells restricts their therapeutic application.
Purpose of the Study:
- To investigate the potential of interleukin-21 (IL-21) in inducing human CD8 TSCM cells.
- To evaluate the therapeutic efficacy of IL-21-generated CD8 TSCM cells in a melanoma model.
Main Methods:
- Naive CD8 T cells were stimulated with IL-21 to generate TSCM cells (defined as CD45RA+CD45RO-CD62L+CCR7+CD122+CD95+).
- Adoptive transfer of these cells into an A375 melanoma mouse model.
- Mechanistic studies involving the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway analysis.
Main Results:
- IL-21 significantly enhanced the generation of CD8 TSCM cells compared to other common gamma-chain cytokines.
- Adoptively transferred IL-21-induced TSCM cells exhibited potent antitumor responses against melanoma.
- IL-21 modulated the JAK/STAT3 pathway, influencing the expression of key transcription factors (T-bet, SOCS1, eomesodermin, GATA3).
Conclusions:
- IL-21 is a potent inducer of human CD8 TSCM cells.
- IL-21-generated CD8 TSCM cells hold promise for adoptive immunotherapy against melanoma.
- This study elucidates a novel mechanism for TSCM cell generation and highlights IL-21's therapeutic potential.
More Related Videos
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Embryonic Stem Cells
Feedback Inhibition
Adult Stem Cells
Meristems and Plant Growth
Primary and Secondary Growth in Roots and Shoots

